TY - JOUR AU - Lam T. AU - Kim H. AU - Fang X. AU - Welborn T. AU - Ueshima H. AU - Hirakawa Y. AU - Woodward Mark AU - Ho S. AU - Suh I. AU - Giles G. AB -

OBJECTIVE: To assess whether body mass index (BMI) modifies the associations of lipids with coronary heart disease (CHD). METHODS: In the Asia Pacific Cohort Studies Collaboration, total cholesterol (TC), high density lipoprotein cholesterol (HDLC) and triglycerides (TG) were measured for 333,297, 71,777 and 84,015 participants, respectively. All participants had measured BMI, categorized into underweight, normal, high-normal, overweight and obese, using standard definitions. For each BMI subgroup the effects of lipids on CHD were estimated per 1 standard deviation (SD) increase using Cox proportional hazard models, stratified by study and sex, adjusted for age and smoking. They were compared across the BMI groups, testing for interactions. RESULTS: In the analyses for TC, HDLC and TG, there were 3121, 714 and 808 CHD events during a mean follow-up of 6.7 years. The risk of CHD increased monotonically with increasing TC and decreasing HDLC in all BMI subgroups without evidence of heterogeneity (p for interaction > 0.4). In contrast, the hazard ratio for CHD for a one SD increase in log-transformed TG increased from 1.07 (95%CI 0.72-1.59) in underweight, 1.26 (1.10-1.44) in normal weight, 1.27 (1.08-1.49) in high-normal weight, 1.37 (1.22-1.55) in overweight, to 1.61(1.30-1.99) in obesity (p = 0.01 for interaction trend). These associations were attenuated (p = 0.07 for interaction) but remained significant in the overweight and obese after further adjustment for TC and HDLC. CONCLUSIONS: Greater excess body weight exacerbated the effects of TG, but not TC or HDLC, on CHD, suggesting that additional effort is required to reduce TG in the overweight and obese.

AD - The George Institute for Global Health, University of Sydney, Australia.
School of Public Health, The University of Hong Kong, Hong Kong, China.
Department of Medicine and Pharmacology, University of Western Australia, Nedlands, Australia.
Cardiovascular and Metabolic Diseases Etiology Research Center, Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, South Korea.
School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
Evidence-Based Medical Center, Xuanwu Hospital, Capital Medical University, Beijing, China.
Department of Public Health, Center for Epidemiologic Research in Asia, Shiga University of Medical Science, Japan.
Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Cancer Epidemiology Centre, The Cancer Council, Victoria, Australia.
The George Institute for Global Health, University of Sydney, Australia; The George Institute for Global Health, Nuffield Department of Population Health, University of Oxford, UK; Department of Epidemiology, Johns Hopkins University, Baltimore, MD, USA. AN - 26844192 BT - Prev Med Rep C2 - PMC4733095 DP - NLM ET - 2016/02/05 LA - eng LB - AUS
PROF
FY16 N1 - Hirakawa, Yoichiro
Lam, Tai-Hing
Welborn, Timothy
Kim, Hyeon Chang
Ho, Suzanne
Fang, Xianghua
Ueshima, Hirotsugu
Suh, Il
Giles, Graham
Woodward, Mark
Asia Pacific Cohort Studies Collaboration
United States
Prev Med Rep. 2015 Dec 30;3:79-82. doi: 10.1016/j.pmedr.2015.12.012. eCollection 2016 Jun. N2 -

OBJECTIVE: To assess whether body mass index (BMI) modifies the associations of lipids with coronary heart disease (CHD). METHODS: In the Asia Pacific Cohort Studies Collaboration, total cholesterol (TC), high density lipoprotein cholesterol (HDLC) and triglycerides (TG) were measured for 333,297, 71,777 and 84,015 participants, respectively. All participants had measured BMI, categorized into underweight, normal, high-normal, overweight and obese, using standard definitions. For each BMI subgroup the effects of lipids on CHD were estimated per 1 standard deviation (SD) increase using Cox proportional hazard models, stratified by study and sex, adjusted for age and smoking. They were compared across the BMI groups, testing for interactions. RESULTS: In the analyses for TC, HDLC and TG, there were 3121, 714 and 808 CHD events during a mean follow-up of 6.7 years. The risk of CHD increased monotonically with increasing TC and decreasing HDLC in all BMI subgroups without evidence of heterogeneity (p for interaction > 0.4). In contrast, the hazard ratio for CHD for a one SD increase in log-transformed TG increased from 1.07 (95%CI 0.72-1.59) in underweight, 1.26 (1.10-1.44) in normal weight, 1.27 (1.08-1.49) in high-normal weight, 1.37 (1.22-1.55) in overweight, to 1.61(1.30-1.99) in obesity (p = 0.01 for interaction trend). These associations were attenuated (p = 0.07 for interaction) but remained significant in the overweight and obese after further adjustment for TC and HDLC. CONCLUSIONS: Greater excess body weight exacerbated the effects of TG, but not TC or HDLC, on CHD, suggesting that additional effort is required to reduce TG in the overweight and obese.

PY - 2016 SN - 2211-3355 (Electronic)
2211-3355 (Linking) SP - 79 EP - 82 T2 - Prev Med Rep TI - The impact of body mass index on the associations of lipids with the risk of coronary heart disease in the Asia Pacific region VL - 3 Y2 - FY16 ER -